Nanobiotix S.A.
Nanobiotix S.A. (NBTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NBTX · as of Jun 9, 2026
Key Statistics
Explore Nanobiotix S.A. Data
nbtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The NBTX analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $38.00, representing +5.91% upside from the current price of $35.88.
Competitors & Peers
nbtx competitorsNBTX
ABUS
EYPT
GHRS
KURA
LENZStock Performance
Full HistoryAbout Nanobiotix S.A.
Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspensi…
what is nanobiotix s.a. · nbtx stock overview · nanobiotix s.a. company profile · who is nanobiotix s.a. ceo · nbtx NASDAQ · nanobiotix s.a. headquarters · nanobiotix s.a. business segments
About Stock Overview & Key Data
Nanobiotix S.A. (NBTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 11, 2020. As of the latest trading session, NBTX stock price is $35.88, with a market capitalization of $1.8B. The stock has returned +679.27% over the past 12 months and +57.74% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Nanobiotix S.A. stock is Buy, with an average 12-month price target of $38.00. In fiscal year 2025, Nanobiotix S.A. reported revenue of $29.6M and net income of -$24.0M. For detailed data — including Nanobiotix S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Nanobiotix S.A. (NBTX) stock price is $35.88. The stock is traded on NASDAQ under the ticker symbol NBTX. The 52-week range is $4.18 – $57.14.